Trends, Prevalence, and Outcomes of Sudden Cardiac Arrest Post Cardiac Transplant: A Nationwide 16-Year Study.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 12 05 2021
accepted: 20 05 2021
pubmed: 1 8 2021
medline: 14 6 2022
entrez: 31 7 2021
Statut: ppublish

Résumé

Heart transplantation is the most effective long-term therapy for end-stage heart disease. There is limited data related to sudden cardiac arrest (SCA) in postheart transplant recipients. We aimed to describe the trends, and rate of SCA following heart transplantation and thereby identify clinical predictors as well as outcomes of SCA in patients post-transplant. We queried the National Inpatient Sample (NIS) with administrative codes for SCA and heart transplant. We assessed baseline differences between SCA and non-SCA admissions, with hazard ratios adjusted for age, gender, CCI, and race. Multivariable logistic regression models were generated to identify the independent predictors for SCA. There was a total of 30,020 hospitalizations of heart transplant recipients between 1999 and 2014 in the United States and among these 1,953 patients (6.5%) suffered SCA with an increasing trend of admissions for SCA. Among the patients who suffered from SCA, 18.83% died during the same hospitalization, 19.29% were discharged to a long-term facility, and 61.38% were discharged home. Multivariate analysis demonstrated that conduction system disorders (Hazard ratio [95% confidence interval]; 7.1 [4.5-11.1]), female gender (HR:1.2 [1.1-1.3]), diabetes (HR:1.4 [1.2-1.6]), and hypertension (HR:1.2 [1.1-1.4]) were the strongest predictors for SCA. SCA hospitalizations occur in 6.5% of patients post cardiac transplant and have been increasing from 1999 to 2014. Conduction block, graft rejection, female gender, hypertension, diabetes are independent predictors for SCA in heart transplant recipients.

Identifiants

pubmed: 34330560
pii: S0146-2806(21)00116-X
doi: 10.1016/j.cpcardiol.2021.100901
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100901

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Ameesh Isath (A)

Department of Medicine, Mount Sinai Morningside and Mount Sinai West, NYC, NY; Department of Cardiology, Westchester Medical Center, Westchester, NY.

Sriram D Rao (SD)

Advanced Heart Failure/Transplantation Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; University of New South Wales, Sydney, NSW, Australia; Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.

Gregory P Siroky (GP)

Department of Cardiology, Division of Electrophysiology, Mount Sinai Morningside and West, NYC, NY.

Deepak Padmanabhan (D)

Department of Electrophysiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, India.

Dhrubajyoti Bandyopadhyay (D)

Department of Cardiology, Westchester Medical Center, Westchester, NY.

Chayakrit Krittanawong (C)

Section of Cardiology, Baylor College of Medicine, Houston, TX, USA.

Selma Mohammed (S)

Department of Cardiovascular Medicine, MedStar Washington Hospital Center, Washington, DC.

C Anwar A Chahal (CAA)

Advanced Heart Failure/Transplantation Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cardiology, Mayo Clinic, Rochester, MN.

Stuthi Perimbeti (S)

Department of Medicine, Mount Sinai Morningside and Mount Sinai West, NYC, NY.

Davendra Mehta (D)

Department of Cardiology, Division of Electrophysiology, Mount Sinai Morningside and West, NYC, NY.

Johanna Contreras (J)

Department of Cardiology, Division of Advanced Heart Failure and Transplant, Mount Sinai Morningside and West, NYC, NY. Electronic address: johanna.contreras@mountsinai.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH